Merit Medical Systems Total Assets 2010-2024 | MMSI

Merit Medical Systems total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Merit Medical Systems total assets for the quarter ending September 30, 2024 were $2.378B, a 31.49% increase year-over-year.
  • Merit Medical Systems total assets for 2023 were $2.325B, a 39.74% increase from 2022.
  • Merit Medical Systems total assets for 2022 were $1.664B, a 0.95% increase from 2021.
  • Merit Medical Systems total assets for 2021 were $1.648B, a 0.97% decline from 2020.
Merit Medical Systems Annual Total Assets
(Millions of US $)
2023 $2,325
2022 $1,664
2021 $1,648
2020 $1,664
2019 $1,757
2018 $1,620
2017 $1,112
2016 $943
2015 $779
2014 $747
2013 $728
2012 $705
2011 $447
2010 $369
2009 $272
Merit Medical Systems Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,378
2024-06-30 $2,372
2024-03-31 $2,326
2023-12-31 $2,325
2023-09-30 $1,809
2023-06-30 $1,838
2023-03-31 $1,684
2022-12-31 $1,664
2022-09-30 $1,633
2022-06-30 $1,632
2022-03-31 $1,630
2021-12-31 $1,648
2021-09-30 $1,643
2021-06-30 $1,642
2021-03-31 $1,652
2020-12-31 $1,664
2020-09-30 $1,671
2020-06-30 $1,716
2020-03-31 $1,749
2019-12-31 $1,757
2019-09-30 $1,762
2019-06-30 $1,736
2019-03-31 $1,690
2018-12-31 $1,620
2018-09-30 $1,310
2018-06-30 $1,291
2018-03-31 $1,239
2017-12-31 $1,112
2017-09-30 $1,087
2017-06-30 $1,052
2017-03-31 $1,015
2016-12-31 $943
2016-09-30 $929
2016-06-30 $815
2016-03-31 $803
2015-12-31 $779
2015-09-30 $768
2015-06-30 $755
2015-03-31 $740
2014-12-31 $747
2014-09-30 $747
2014-06-30 $744
2014-03-31 $742
2013-12-31 $728
2013-09-30 $718
2013-06-30 $728
2013-03-31 $712
2012-12-31 $705
2012-09-30 $519
2012-06-30 $500
2012-03-31 $489
2011-12-31 $447
2011-09-30 $419
2011-06-30 $458
2011-03-31 $380
2010-12-31 $369
2010-09-30 $364
2010-06-30 $280
2010-03-31 $277
2009-12-31 $272
2009-09-30 $265
2009-06-30 $257
2009-03-31 $241
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.972B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95